New


Journal

MedChemComm
ISSN: 2040-2511
Titre abrégé: Medchemcomm
Pays: England
ID NLM: 101531525

Informations de publication

Date de publication:
01 Jun 2019
Historique:
received: 16 04 2019
accepted: 18 05 2019
entrez: 16 7 2019
pubmed: 16 7 2019
medline: 16 7 2019
Statut: epublish

Résumé

Due to the rapid development of antimicrobial resistance, the discovery of new antibacterials is essential in the fight against potentially lethal infections. The DNA gyrase B (GyrB) subunit of bacterial DNA gyrase is an excellent target for the design of antibacterials, as it has been clinically validated by novobiocin. However, there are currently no drugs in clinical use that target GyrB. We prepared a new series of

Identifiants

pubmed: 31303999
doi: 10.1039/c9md00224c
pii: c9md00224c
pmc: PMC6596384
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1007-1017

Références

ACS Med Chem Lett. 2016 Feb 16;7(4):374-8
pubmed: 27096044
J Med Chem. 2015 Jul 23;58(14):5501-21
pubmed: 26098163
Eur J Med Chem. 2019 Apr 1;167:269-290
pubmed: 30776691
Arch Pharm (Weinheim). 2018 Jan;351(1):
pubmed: 29239018
Bioorg Med Chem. 2017 Jan 1;25(1):338-349
pubmed: 27838171
Appl Microbiol Biotechnol. 2011 Nov;92(3):479-97
pubmed: 21904817
J Med Chem. 2012 Jul 26;55(14):6413-26
pubmed: 22731783
PLoS One. 2013 Dec 26;8(12):e84409
pubmed: 24386374
Nature. 2016 Jan 21;529(7586):336-43
pubmed: 26791724
J Med Chem. 2014 Jul 24;57(14):6060-82
pubmed: 24959892
Eur J Med Chem. 2018 Jun 25;154:117-132
pubmed: 29778894
Expert Opin Ther Pat. 2019 Mar;29(3):171-180
pubmed: 30686070
Curr Top Med Chem. 2014;14(1):130-51
pubmed: 24236722
J Med Chem. 2016 Oct 13;59(19):8941-8954
pubmed: 27541007
ACS Infect Dis. 2015 Jan 9;1(1):4-41
pubmed: 27620144
Eur J Med Chem. 2016 Jul 19;117:197-211
pubmed: 27100032
J Mol Biol. 1997 Apr 4;267(3):727-48
pubmed: 9126849
Front Immunol. 2018 May 30;9:1068
pubmed: 29910799
J Enzyme Inhib Med Chem. 2013 Jun;28(3):419-35
pubmed: 22380774
Biochemistry. 2014 Mar 18;53(10):1565-74
pubmed: 24576155
Future Med Chem. 2018 May 1;10(10):1207-1227
pubmed: 29787300
J Med Chem. 2000 Aug 10;43(16):3052-66
pubmed: 10956213
J Med Chem. 2014 Nov 13;57(21):8792-816
pubmed: 25317480
J Med Chem. 2013 Nov 14;56(21):8712-35
pubmed: 24098982
ChemMedChem. 2018 Jan 22;13(2):186-198
pubmed: 29206345
J Med Chem. 2015 Aug 13;58(15):6179-94
pubmed: 26126187

Auteurs

Nace Zidar (N)

University of Ljubljana , Faculty of Pharmacy , Aškerčeva cesta 7 , 1000 Ljubljana , Slovenia . Email: nace.zidar@ffa.uni-lj.si ; ; Tel: +386 1 4769578.

Helena Macut (H)

University of Ljubljana , Faculty of Pharmacy , Aškerčeva cesta 7 , 1000 Ljubljana , Slovenia . Email: nace.zidar@ffa.uni-lj.si ; ; Tel: +386 1 4769578.

Tihomir Tomašič (T)

University of Ljubljana , Faculty of Pharmacy , Aškerčeva cesta 7 , 1000 Ljubljana , Slovenia . Email: nace.zidar@ffa.uni-lj.si ; ; Tel: +386 1 4769578.

Lucija Peterlin Mašič (L)

University of Ljubljana , Faculty of Pharmacy , Aškerčeva cesta 7 , 1000 Ljubljana , Slovenia . Email: nace.zidar@ffa.uni-lj.si ; ; Tel: +386 1 4769578.

Janez Ilaš (J)

University of Ljubljana , Faculty of Pharmacy , Aškerčeva cesta 7 , 1000 Ljubljana , Slovenia . Email: nace.zidar@ffa.uni-lj.si ; ; Tel: +386 1 4769578.

Anamarija Zega (A)

University of Ljubljana , Faculty of Pharmacy , Aškerčeva cesta 7 , 1000 Ljubljana , Slovenia . Email: nace.zidar@ffa.uni-lj.si ; ; Tel: +386 1 4769578.

Päivi Tammela (P)

Drug Research Program , Division of Pharmaceutical Biosciences , Faculty of Pharmacy , University of Helsinki , P.O. Box 56 (Viikinkaari 5 E) , Helsinki FI-00014 , Finland.

Danijel Kikelj (D)

University of Ljubljana , Faculty of Pharmacy , Aškerčeva cesta 7 , 1000 Ljubljana , Slovenia . Email: nace.zidar@ffa.uni-lj.si ; ; Tel: +386 1 4769578.

Classifications MeSH